225 related articles for article (PubMed ID: 23287548)
1. Nuclear matrix-targeting of the osteogenic factor Runx2 is essential for its recognition and activation of the alkaline phosphatase gene.
Weng JJ; Su Y
Biochim Biophys Acta; 2013 Mar; 1830(3):2839-52. PubMed ID: 23287548
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA of alkaline phosphatase inhibits matrix mineralization.
Kotobuki N; Matsushima A; Kato Y; Kubo Y; Hirose M; Ohgushi H
Cell Tissue Res; 2008 May; 332(2):279-88. PubMed ID: 18317813
[TBL] [Abstract][Full Text] [Related]
3. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
[TBL] [Abstract][Full Text] [Related]
4. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.
Chen Y; Hu Y; Yang L; Zhou J; Tang Y; Zheng L; Qin P
Cell Biol Int; 2017 Aug; 41(8):822-832. PubMed ID: 28462510
[TBL] [Abstract][Full Text] [Related]
5. Osteogenic differentiation of C2C12 myogenic progenitor cells requires the Fos-related antigen Fra-1 - a novel target of Runx2.
Yu S; Geng Q; Sun F; Yu Y; Pan Q; Hong A
Biochem Biophys Res Commun; 2013 Jan; 430(1):173-8. PubMed ID: 23159633
[TBL] [Abstract][Full Text] [Related]
6. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
7. Promotion of osteoblast differentiation in mesenchymal cells through Cbl-mediated control of STAT5 activity.
Dieudonne FX; Sévère N; Biosse-Duplan M; Weng JJ; Su Y; Marie PJ
Stem Cells; 2013 Jul; 31(7):1340-9. PubMed ID: 23533197
[TBL] [Abstract][Full Text] [Related]
8. MiR-433 mediates ERRγ-suppressed osteoblast differentiation via direct targeting to Runx2 mRNA in C3H10T1/2 cells.
Kim EJ; Kang IH; Lee JW; Jang WG; Koh JT
Life Sci; 2013 Mar; 92(10):562-8. PubMed ID: 23353875
[TBL] [Abstract][Full Text] [Related]
9. Small nuclear ribonucleoprotein polypeptide N (Sm51) promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating Runx2.
Meng F; Xu L; Huang S; Liu Y; Hou Y; Wang K; Jiang X; Li G
Cell Tissue Res; 2016 Oct; 366(1):155-62. PubMed ID: 27184949
[TBL] [Abstract][Full Text] [Related]
10. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation.
Kwun IS; Cho YE; Lomeda RA; Shin HI; Choi JY; Kang YH; Beattie JH
Bone; 2010 Mar; 46(3):732-41. PubMed ID: 19913120
[TBL] [Abstract][Full Text] [Related]
11. Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.
Wang G; Zhang X; Yu B; Ren K
Mol Med Rep; 2015 Jul; 12(1):877-84. PubMed ID: 25816130
[TBL] [Abstract][Full Text] [Related]
12. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations.
Isenmann S; Cakouros D; Zannettino A; Shi S; Gronthos S
J Bone Miner Res; 2007 Jun; 22(6):897-906. PubMed ID: 17352650
[TBL] [Abstract][Full Text] [Related]
13. Regulation of osteoblasts by alkaline phosphatase in ankylosing spondylitis.
Jo S; Han J; Lee YL; Yoon S; Lee J; Wang SE; Kim TH
Int J Rheum Dis; 2019 Feb; 22(2):252-261. PubMed ID: 30415492
[TBL] [Abstract][Full Text] [Related]
14. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
[TBL] [Abstract][Full Text] [Related]
15. Mineralization initiation of MC3T3-E1 preosteoblast is suppressed under simulated microgravity condition.
Hu LF; Li JB; Qian AR; Wang F; Shang P
Cell Biol Int; 2015 Apr; 39(4):364-72. PubMed ID: 25318973
[TBL] [Abstract][Full Text] [Related]
16. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic potential of punica granatum through matrix mineralization, cell cycle progression and runx2 gene expression in primary rat osteoblasts.
Siddiqui S; Arshad M
Daru; 2014 Nov; 22(1):72. PubMed ID: 25409708
[TBL] [Abstract][Full Text] [Related]
18. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
Young DW; Pratap J; Javed A; Weiner B; Ohkawa Y; van Wijnen A; Montecino M; Stein GS; Stein JL; Imbalzano AN; Lian JB
J Cell Biochem; 2005 Mar; 94(4):720-30. PubMed ID: 15565649
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-214 inhibits the osteogenic differentiation of human osteoblasts through the direct regulation of baculoviral IAP repeat-containing 7.
Liu J; Li Y; Luo M; Yuan Z; Liu J
Exp Cell Res; 2017 Feb; 351(2):157-162. PubMed ID: 28109866
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-222-3p activity promoted osteogenic differentiation of hBMSCs by regulating Smad5-RUNX2 signal axis.
Yan J; Guo D; Yang S; Sun H; Wu B; Zhou D
Biochem Biophys Res Commun; 2016 Feb; 470(3):498-503. PubMed ID: 26809090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
